The restraints were derived from (i) NOE restraints from intermolecular and intramolecular cross-peaks in NOESY spectra (described in NMR spectroscopy section), (ii) TALOS derived p53 TAD2 and FOXO4-DRI backbone dihedral angles, (iii) hydrogen bond restraints (regions p53 residues 4752, FOXO4-DRI residues 918
J Ethnopharmacol 321(10):117541
For instance, the promoter regions of inflammation-related genes (e.g., IL-6 and TNF-) in patients with gouty arthritis exhibit hypomethylation, potentially promoting inflammation directly and independently of hyperuricemia ( CXCL8 and PTGS2 ) within macrophages, thereby prolonging inflammatory responses ( 2.1.4 Impaired intestinal and renal excretion Approximately 90% of patients with gout exhibit impaired uric acid excretion, primarily due to reduced renal urate clearance ( 2.1.5 Synergism with metabolic syndrome Gout is closely associated with metabolic syndrome components, including obesity, insulin resistance, and hypertension ( 2.1.6 Transition from asymptomatic hyperuricemia to gout Only 10%20% of individuals with hyperuricemia develop gout, implicating critical roles for other regulatory factors (e.g., local tissue microenvironment and crystal-promoting factors) (Zhang, 2023)
Did you guys ever send the stuff out for third-party testing
